BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28784093)

  • 1. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
    Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
    Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.
    Guiriguet-Capdevila C; Muñoz-Ortiz L; Rivero-Franco I; Vela-Vallespín C; Vilarrubí-Estrella M; Torres-Salinas M; Grau-Cano J; Burón-Pust A; Hernández-Rodríguez C; Fuentes-Peláez A; Reina-Rodríguez D; De León-Gallo R; Mendez-Boo L; Torán-Monserrat P
    BMC Cancer; 2014 Mar; 14():232. PubMed ID: 24685117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test.
    Portillo I; Arana-Arri E; Gutiérrez-Ibarluzea I; Bilbao I; Luis Hurtado J; Sarasqueta C; Idigoras I; Bujanda L;
    Eur J Public Health; 2018 Dec; 28(6):1143-1148. PubMed ID: 29982586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
    Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
    Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Related to Non-participation in the Basque Country Colorectal Cancer Screening Programme.
    Solís-Ibinagagoitia M; Unanue-Arza S; Díaz-Seoane M; Martínez-Indart L; Lebeña-Maluf A; Idigoras I; Bilbao I; Portillo I
    Front Public Health; 2020; 8():604385. PubMed ID: 33363095
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).
    Binefa G; Garcia M; Milà N; Fernández E; Rodríguez-Moranta F; Gonzalo N; Benito L; Clopés A; Guardiola J; Moreno V
    Sci Rep; 2016 Jan; 6():19532. PubMed ID: 26787510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of non-participation in a mass screening program for colorectal cancer in Finland.
    Artama M; Heinävaara S; Sarkeala T; Prättälä R; Pukkala E; Malila N
    Acta Oncol; 2016 Jul; 55(7):870-4. PubMed ID: 27152755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.
    Buron A; Auge JM; Sala M; Román M; Castells A; Macià F; Comas M; Guiriguet C; Bessa X; Castells X;
    PLoS One; 2017; 12(6):e0179864. PubMed ID: 28622365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    de Klerk CM; Gupta S; Dekker E; Essink-Bot ML;
    Gut; 2018 Apr; 67(4):679-687. PubMed ID: 28073892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental disorders, participation, and trajectories in the Danish colorectal cancer programme: a population-based cohort study.
    Thomsen MK; Jørgensen MD; Pedersen L; Erichsen R; Sørensen HT; Mikkelsen EM
    Lancet Psychiatry; 2023 Jul; 10(7):518-527. PubMed ID: 37353263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
    Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
    Elife; 2023 Jan; 12():. PubMed ID: 36695411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study.
    Clarke N; Kearney PM; Gallagher P; McNamara D; O'Morain CA; Sharp L
    Prev Med; 2021 Apr; 145():106430. PubMed ID: 33482227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.